USE OF sGC STIMULATORS FOR THE TREATMENT OF GASTROINTESTINAL SPHINCTER DYSFUNCTION
The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising an sGC stimulator or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents, for the treatment of a gastrointestinal sphincter disorder. Gastro...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
19.10.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to methods, uses, pharmaceutical compositions and kits comprising an sGC stimulator or a pharmaceutically acceptable salt thereof, alone or in combination with one or more additional therapeutic agents, for the treatment of a gastrointestinal sphincter disorder. Gastrointestinal sphincter disorders include, but are not limited to, an achalasia of a sphincter of the gastrointestinal tract, a spastic sphincter of the gastrointestinal tract or sphincter spasms, or a hypertensive sphincter of the gastrointestinal tract.
La présente invention concerne des procédés, utilisations, compositions pharmaceutiques et kits comprenant un stimulateur de la sGC ou un sel pharmaceutiquement acceptable de celui-ci, seul ou en combinaison avec un ou plusieurs agents thérapeutiques supplémentaires, pour le traitement d'un trouble du sphincter gastro-intestinal. Les troubles du sphincter gastro-intestinal comprennent, mais sans s'y limiter, une achalasie d'un sphincter du tractus gastro-intestinal, un sphincter spastique du tractus gastro-intestinal ou des spasmes du sphincter, ou un sphincter hypertendu du tractus gastro-intestinal. |
---|---|
Bibliography: | Application Number: WO2016US66357 |